Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

New advances in hepatocellular carcinoma.

Pascual S, Herrera I, Irurzun J.

World J Hepatol. 2016 Mar 28;8(9):421-38. doi: 10.4254/wjh.v8.i9.421. Review.

2.

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.

Xu DW, Wan P, Xia Q.

World J Gastroenterol. 2016 Mar 28;22(12):3325-34. doi: 10.3748/wjg.v22.i12.3325. Review.

3.

Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future.

Soriano A, Varona A, Gianchandani R, Moneva ME, Arranz J, Gonzalez A, Barrera M.

World J Hepatol. 2016 Jan 8;8(1):58-68. doi: 10.4254/wjh.v8.i1.58. Review.

4.

Differentiation between Malignant and Benign Solitary Lesions in the Liver with (18)FDG PET/CT: Accuracy of Age-related Diagnostic Standard.

Xia Q, Feng Y, Wu C, Huang G, Liu J, Chen T, Sun X, Song S, Tong L, Ni Y.

J Cancer. 2015 Jan 1;6(1):40-7. doi: 10.7150/jca.10422.

5.

Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study.

Qin S, Cheng Y, Liang J, Shen L, Bai Y, Li J, Fan J, Liang L, Zhang Y, Wu G, Rau KM, Yang TS, Jian Z, Liang H, Sun Y.

Oncologist. 2014 Nov;19(11):1169-78. doi: 10.1634/theoncologist.2014-0190.

6.

Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.

Teng F, Wang GH, Tao YF, Guo WY, Wang ZX, Ding GS, Shi XM, Fu ZR.

World J Gastroenterol. 2014 Aug 21;20(31):10900-7. doi: 10.3748/wjg.v20.i31.10900.

7.

Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.

Grąt M, Kornasiewicz O, Lewandowski Z, Hołówko W, Grąt K, Kobryń K, Patkowski W, Zieniewicz K, Krawczyk M.

World J Surg. 2014 Oct;38(10):2698-707. doi: 10.1007/s00268-014-2647-3.

8.

Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.

Wan P, Zhang JJ, Li QG, Xu N, Zhang M, Chen XS, Han LZ, Xia Q.

World J Gastroenterol. 2014 Apr 21;20(15):4393-400. doi: 10.3748/wjg.v20.i15.4393.

9.

Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.

Wan P, Zhang J, Long X, Li Q, Xu N, Zhang M, Chen X, Han L, Xia Q.

Eur J Gastroenterol Hepatol. 2014 May;26(5):553-61. doi: 10.1097/MEG.0000000000000070.

10.

"Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China.

Lei JY, Wang WT, Yan LN.

World J Gastroenterol. 2013 Nov 28;19(44):8093-8. doi: 10.3748/wjg.v19.i44.8093.

11.

Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis.

Lei JY, Wang WT, Yan LN.

World J Gastroenterol. 2013 Sep 28;19(36):6077-83. doi: 10.3748/wjg.v19.i36.6077.

12.

Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma.

Xing T, Huang L, Yu Z, Zhong L, Wang S, Peng Z.

PLoS One. 2013 Aug 6;8(8):e71251. doi: 10.1371/journal.pone.0071251.

13.

Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy.

Miao Q, Bi LL, Li X, Miao S, Zhang J, Zhang S, Yang Q, Xie YH, Zhang J, Wang SW.

Int J Mol Sci. 2013 Jan 11;14(1):1370-82. doi: 10.3390/ijms14011370.

14.

Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.

Lai Q, Melandro F, Pinheiro RS, Donfrancesco A, Fadel BA, Levi Sandri GB, Rossi M, Berloco PB, Frattaroli FM.

Int J Hepatol. 2012;2012:893103. doi: 10.1155/2012/893103.

15.

Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation.

He J, Zeng ZC, Fan J, Zhou J, Sun J, Chen B, Yang P, Wang BL, Zhang BH, Zhang JY.

BMC Cancer. 2011 Nov 22;11:492. doi: 10.1186/1471-2407-11-492.

16.

Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.

Hu J, Wang Z, Fan J, Dai Z, He YF, Qiu SJ, Huang XW, Sun J, Xiao YS, Song K, Shi YH, Sun QM, Yang XR, Shi GM, Yu L, Yang GH, Ding ZB, Gao Q, Tang ZY, Zhou J.

PLoS One. 2011;6(10):e26003. doi: 10.1371/journal.pone.0026003.

Items per page

Supplemental Content

Support Center